Sign In
Buy UNH
$400.96
+1.43 (+0.358%)
At Close: Jun 18, 2026
Prediction: 1 Value Stock That Will Be Worth More Than Palantir by the End of 2026
01:10pm, Saturday, 01'st Nov 2025
Palantir has seen its valuation soar as investors remain optimistic about the future of AI. Investors may want to start diversifying toward more value stocks amid soaring tech stock valuations.
Medical Stocks To Watch Now – October 30th
05:47am, Saturday, 01'st Nov 2025
Eli Lilly and Company, UnitedHealth Group, and Pfizer are the three Medical stocks to watch today, according to MarketBeat's stock screener tool. Medical stocks are shares of publicly traded companies
Healthcare Stocks To Follow Today – October 30th
05:08am, Saturday, 01'st Nov 2025
UnitedHealth Group, Cardinal Health, Johnson and Johnson, Intuitive Surgical, Hims and Hers Health, McKesson, and Baxter International are the seven Healthcare stocks to watch today, according to Mark
UnitedHealth Group (NYSE:UNH) Stock Price Down 3% Following Analyst Downgrade
04:30am, Friday, 31'st Oct 2025
Shares of UnitedHealth Group Incorporated (NYSE: UNH - Get Free Report) fell 3% during trading on Thursday after Deutsche Bank Aktiengesellschaft downgraded the stock from a buy rating to a hold ratin
UNH - 3 Reasons Not To Buy After 'Beat & Raise'
04:31pm, Thursday, 30'th Oct 2025
United Health (UNH) has rebounded from its lows but remains well below previous highs, attracting value investors seeking mean reversion. Q3 earnings beat expectations modestly, with adjusted EPS and
The Richest 0.1% Are Buying These 3 Dividend Stocks Right Now
10:41am, Thursday, 30'th Oct 2025
When ultra-rich investors start coalescing into the same names or put an unusually large amount of money into a single stock, that should raise more interest.
Top Medical Stocks To Research – October 28th
02:09am, Thursday, 30'th Oct 2025
UnitedHealth Group, Avidity Biosciences, Eli Lilly and Company, Regeneron Pharmaceuticals, and Johnson and Johnson are the five Medical stocks to watch today, according to MarketBeat's stock screener
UnitedHealth: Risk-Reward Profile Signals Time To Hold, Not Buy (Rating Downgrade)
10:34pm, Wednesday, 29'th Oct 2025
UnitedHealth Group delivered better-than-expected Q3 results, beating earnings estimates and raising guidance. UNH faces ongoing profitability pressures from elevated medical utilization and regulator
Does UnitedHealth Stock Have More Upside After Q3 Earnings?
08:21pm, Wednesday, 29'th Oct 2025
UnitedHealth Group's (UNH) stock hasn't received the post-earnings rally that investors may have hoped for, but the medical giant was able to provide subtle signs that its operations are stabilizing.
Calls of the Day: Uber, Datadog, UnitedHealth, Chubb and FTAI Aviation
01:03pm, Wednesday, 29'th Oct 2025
The Investment Committee debate the latest Calls of the Day.
Heard on the Street: UnitedHealth and CVS are pruning their Medicare Advantage businesses to favor profit over size
12:00pm, Wednesday, 29'th Oct 2025
UnitedHealth and CVS are pruning their Medicare Advantage businesses to favor profit over size
UnitedHealth Lifts EPS Outlook Despite Mixed Q3 Results: ETFs in Focus
10:02am, Wednesday, 29'th Oct 2025
UNH posts mixed Q3 results with a revenue miss but lifts its 2025 EPS outlook, boosting interest in healthcare ETFs like IHF and XLV.
Here Are Wednesday's Top Wall Street Analyst Research Calls: United Health, SoFi, Skyworks, Energy Transfer and More
08:35am, Wednesday, 29'th Oct 2025
The futures are trading higher this morning after another stellar day across Wall Street on Tuesday, as all the major indices once again ended higher and continue to print new all-time highs.
UnitedHealth Group's Recovery in Full Swing: Buy While It's Down
07:14am, Wednesday, 29'th Oct 2025
If UnitedHealth Group's NYSE: UNH stock price implosion was driven by margin, earnings, and capital return concerns, the Q3 results put them to rest.
UnitedHealth: Strong Long-Term Fundamentals, But Risks Also Exist
12:36am, Wednesday, 29'th Oct 2025
UnitedHealth Group has outperformed the S&P 500 since my previous Buy and Strong Buy ratings, delivering 33% and 41% total returns. Following Q3 FY2025 earnings review, UNH remains the most expensive
